FDA OVERSIGHT OF CLINICAL TRIALS The US FDA and regulatory free fall

被引:0
|
作者
Wilson, Mark
机构
来源
关键词
D O I
10.1136/bmj.p85
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [1] FDA Oversight of Cell Therapy Clinical Trials
    Au, Patrick
    Hursh, Deborah A.
    Lim, Agnes
    Moos, Malcolm C., Jr.
    Oh, Steven S.
    Schneider, Bruce S.
    Witten, Celia M.
    SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (149)
  • [2] US device industry and FDA "colluded" on legislation to weaken regulatory oversight
    Lenzer, Jeanne
    BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [3] FDA oversight of clinical trials is "grossly inadequate," say experts
    Demasi, Maryanne
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
  • [4] FDA oversight of clinical trials is "grossly inadequate," say experts
    Demasi, Maryanne
    BMJ-BRITISH MEDICAL JOURNAL, 2022, 379
  • [5] FDA's Framework for Regulatory Oversight of LDTs
    Pathak, Bhagyashri
    Terry, Sharon F.
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2014, 18 (12) : 785 - 786
  • [7] US FDA proposes stronger laboratory test oversight
    Furlow, Bryant
    LANCET ONCOLOGY, 2023, 24 (11): : 1175 - 1175
  • [8] Stem cells and the FDA: Regulatory considerations for proceeding to clinical trials
    Fink, Donald W., Jr.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2005, 41 : 7A - 7A
  • [9] FDA - ADMINISTRATION AND OVERSIGHT
    FINE, SD
    FOOD DRUG COSMETIC LAW JOURNAL, 1972, 27 (05): : 278 - 281
  • [10] FDA oversight questioned
    Mitka, Mike
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (22): : 2611 - 2611